Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 Application
2.2.3 End use
2.2.4 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing prevalence of cardiac arrythmia
3.2.1.2 Increasing demand for ambulatory monitoring Devices
3.2.1.3 Rising geriatric population
3.2.1.4 Technological advancements
3.2.2 Market Restraint Analysis
3.2.2.1 High cost and longer turnaround time (TAT)
3.2.2.2 Lack of supportive reimbursement policies
3.2.2.3 False-negative and false-positive results
3.3 ECG Patch and PorTable Holter: Market Analysis Tools
3.3.1 Industry Analysis-Porter’s Five Forces Analysis
3.3.1.1 Bargaining power of buyers: Low
3.3.1.2 Bargaining power of suppliers: High
3.3.1.3 Competitive rivalry: High
3.3.1.4 Threat of new entrants: Low
3.3.1.5 Threat of substitutes: Moderate
3.3.2 PESTEL Analysis
3.3.2.1 Political & legal
3.3.2.2 Social & economic
3.3.2.3 Technological
3.4 Major Deals and Strategic Alliances Analysis
3.4.1 Mergers & Acquisitions
3.4.2 Partnerships
3.5 Penetration & Growth Prospect Mapping
3.5.1 Analysis
3.6 Qualitative Analysis: Distribution Channels of ECG Patch and Holter Monitors Market
3.6.1 List of Key Distributors
3.6.1.1 North America
3.6.1.2 Europe
3.6.1.3 Asia Pacific
3.6.1.4 Latin America
3.6.1.5 Middle East & Africa
3.7 ECG Patch and Holter Monitor Market: Pricing Analysis
3.8 Regulatory Scenario: ECG Patch and Holter Monitor Market
3.9 Qualitative Analysis: COVID-19 Impact on ECG Patch and Holter Monitor Market
Chapter 4 ECG Patch and Holter Monitor Market: Product Analysis
4.1 ECG Patch and Holter Monitor Market Share Analysis, 2021 & 2030
4.2 Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Product
4.3.1 ECG Patch
4.3.1.1 ECG patch market, 2017-2030 (USD Million)
4.3.2 Holter Monitor
4.3.2.1 Holter Monitor market, 2017-2030 (USD Million)
Chapter 5 ECG Patch and Holter Monitor Market: Application Analysis
5.1 ECG Patch and Holter Monitor Application Market Share Analysis, 2021 & 2030
5.2 Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Application
5.3.1 Diagnostics
5.3.1.1 Diagnostics market, 2017-2030 (USD Million)
5.3.2 Monitoring
5.3.2.1 Monitoring market, 2017-2030 (USD Million)
Chapter 6 ECG Patch and Holter Monitor Market: End Use Analysis
6.1 ECG Patch and Holter Monitor by End Use Market Share Analysis, 2021 & 2030
6.2 Segment Dashboard
6.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the End-use
6.3.1 Hospitals & Clinics
6.3.1.1 Hospitals & clinics market, 2017-2030 (USD Million)
6.3.2 Ambulatory Facilities
6.3.2.1 Ambulatory facilities market, 2017-2030 (USD Million)
6.3.3 Others
6.3.3.1 Others market, 2017-2030 (USD Million)
Chapter 7 ECG Patch and Holter Monitors Market: Regional Analysis
7.1 ECG Patch and Holter Monitor Regional Market Share Analysis, 2021 & 2030
7.2 Regional Market Snapshot (Market Size, CAGR)
7.3 SWOT Analysis
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Latin America
7.3.5 Middle East & Africa
7.4 North America
7.4.1 North AMerica ECG Patch and Holter Monitor market, 2017-2030 (USD Million)
7.4.2 U.S.
7.4.2.1 U.S. ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.4.3 Canada
7.4.3.1 Canada ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5 Europe
7.5.1.1 Europe ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5.2 U.K.
7.5.2.1 U.K. ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5.3 Germany
7.5.3.1 Germany ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5.4 France
7.5.4.1 France ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5.5 Italy
7.5.5.1 Italy ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.5.6 Spain
7.5.6.1 Spain ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.6.2 China
7.6.2.1 China ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.6.3 japan
7.6.3.1 Japan ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.6.4 India
7.6.4.1 India ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.6.5 South Korea
7.6.5.1 South korea ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.7 Latin America
7.7.1 Latin America ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.7.2 Brazil
7.7.2.1 Brazil ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.7.3 Mexico
7.7.3.1 Mexico ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.8 Middle East & Africa
7.8.1 Middle East & Africa ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.8.2 Saudi Arabia
7.8.2.1 Saudi Arabia ECG patch and Holter monitor market, 2017-2030 (USD Million)
7.8.3 South Africa
7.8.3.1 South Africa ECG patch and Holter monitor market, 2017-2030 (USD Million)
Chapter 8 Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company/Competition Categorization
8.3 Company Market Position Analysis
8.4 Company Profiles
8.4.1 Nissha Medical Technologies (Vermed)
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Medtronic PLC
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Hill-Rom Services, Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 iRhythm Technologies, Inc.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Nihon Kohden Corporation
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Koninklijke Philips N.V.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 GE Healthcare
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 FU.K.UDA DENSHI CO., LTD.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.9 Spacelabs Healthcare (Subsidiary Of OSI Systems, Inc.)
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.10 Alivecor, Inc.
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Cardiac Insight Inc.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
8.4.12 VitalConnect
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 LifeSignals, Inc.
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 Bardy Diagnostics, Inc.
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Nasiff Associates, Inc.
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
8.4.16 Midmark Corporation
8.4.16.1 Company overview
8.4.16.2 Financial performance
8.4.16.3 Product benchmarking
8.4.16.4 Strategic initiatives
8.4.17 Lief Therapeutics, Inc.
8.4.17.1 Company overview
8.4.17.2 Product benchmarking
8.4.17.3 Strategic initiatives
8.4.18 Schiller AG
8.4.18.1 Company overview
8.4.18.2 Financial performance
8.4.18.3 Product benchmarking
8.4.18.4 Strategic initiatives